# Aids Reviews

> Aids Reviews


## Posts

- [Research on differences in sexual orientation and identity](https://aidsreviews.com/en/uncategorized/research-on-differences-in-sexual-orientation-and-identity/)
- [Medicine at bedside or with smartphone?](https://aidsreviews.com/en/uncategorized/medicine-at-bedside-or-with-smartphone/)
- [Dental procedures in people living with HIV: a narrative review](https://aidsreviews.com/en/uncategorized/dental-procedures-in-people-living-with-hiv-a-narrative-review/)
- [Trends and perspectives in the HIV vaccine research over the past thirty-five years: A scientometrics analysis through CiteSpace](https://aidsreviews.com/en/uncategorized/trends-and-perspectives-in-the-hiv-vaccine-research-over-the-past-thirty-five-years-a-scientometrics-analysis-through-citespace/)
- [Baseline characteristics of people living with HIV with different CD4(+) T cell depletion](https://aidsreviews.com/en/uncategorized/baseline-characteristics-of-people-living-with-hiv-with-different-cd4-t-cell-depletion/)
- [Global incidence of chlamydia infection and HIV pre-exposure prophylaxis](https://aidsreviews.com/en/uncategorized/global-incidence-of-chlamydia-infection-and-hiv-pre-exposure-prophylaxis/)
- [HIV-1 genotyping and drug resistance mutations in Morocco (2009-2024): a systematic review addressing critical gaps in molecular surveillance](https://aidsreviews.com/en/uncategorized/hiv-1-genotyping-and-drug-resistance-mutations-in-morocco-2009-2024-a-systematic-review-addressing-critical-gaps-in-molecular-surveillance/)
- [Beating HIV from day 1: strengthening same-day antiretroviral therapy in South Africa: challenges, realities, and the path forward](https://aidsreviews.com/en/uncategorized/beating-hiv-from-day-1-strengthening-same-day-antiretroviral-therapy-in-south-africa-challenges-realities-and-the-path-forward/)
- [Avian influenza in the context of a pandemic challenge](https://aidsreviews.com/en/uncategorized/avian-influenza-in-the-context-of-a-pandemic-challenge/)
- [Integrating business management strategies to address HIV stigma and support employees in diverse workplaces](https://aidsreviews.com/en/2025/integrating-business-management-strategies-to-address-hiv-stigma-and-support-employees-in-diverse-workplaces/)
- [Research trends and hotspots in HIV pre-exposure prophylaxis: a bibliometric analysis and visual mapping](https://aidsreviews.com/en/2025/research-trends-and-hotspots-in-hiv-pre-exposure-prophylaxis-a-bibliometric-analysis-and-visual-mapping/)
- [Interventions to prevent vertical transmission of HIV: an umbrella review of systematic reviews and meta-analyses](https://aidsreviews.com/en/2025/interventions-to-prevent-vertical-transmission-of-hiv-an-umbrella-review-of-systematic-reviews-and-meta-analyses/)
- [New CDC guidelines for HIV post-exposure prophylaxis](https://aidsreviews.com/en/2025/new-cdc-guidelines-for-hiv-post-exposure-prophylaxis/): Acquisition of HIV infection following potential exposure may occur occupationally in health care workers or, much more frequently, outside working sites, in persons engaged in high-risk behaviors, either sexual or through injection drug use. The use of antiretroviral drugs either before or soon after HIV exposure may prevent primary viral infection. The US CDC released updated recommendations for non-occupational post-exposure prophylaxis (PEP) in May 2025 (Tanner et al., MMWR 2025; 74: 1-56). The major news in the CDC guidelines for HIV PEP refers to five aspects. First, encourage taking meds within 24 h, and no later than 3 days post-exposure. […]
- [Cloning and editing of animals for human benefit](https://aidsreviews.com/en/2025/cloning-and-editing-of-animals-for-human-benefit/): Several international associations have banned the use of genetically modified animals in sports competitions. The latest development has been the Argentine Polo Association, following the announcement that cloned specimens of Pureza, a mare that has won multiple awards, have been produced. In addition, the five clones of the horse have an alteration in the myostatin gene, produced by gene editing, with the purpose of modifying its musculature and increasing its speed (Kavanagh, Nature 2025). There is growing concern about the generation of laboratory animals with new properties and that these new “artificial” beings may alter ecosystems, as invasive species. It […]
- [Why is the Bill and Melinda Gates Foundation going extinct?](https://aidsreviews.com/en/2025/why-is-the-bill-and-melinda-gates-foundation-going-extinct/): The prestigious medical magazine The New England Journal of Medicine has published an article announcing and arguing the reasons that have led Bill Gates to extinguish his foundation (Phillips S. N Engl J Med 2025). Reading the text leaves no one indifferent. Health and prosperity After World War II, the Marshall Plan in Europe allowed for a rapid recovery from the devastation of the continent. West Germany, one of the most destroyed areas, was rebuilt in a few decades. Its transformation into an industrial power is known as the “German miracle”. Later, social prosperity in the rest of the surrounding […]
- [Breaking HIV stigma: the role of communication and treatment adherence in the mental health of injected drug users in Pakistan](https://aidsreviews.com/en/2025/breaking-hiv-stigma-the-role-of-communication-and-treatment-adherence-in-the-mental-health-of-injected-drug-users-in-pakistan-2/): Introduction The National AIDS Control Program Pakistan reports 0.24 million HIV patients indicating an alarm of danger1. Out of 46,912 HIV/AIDS patients, only 26,093 are receiving treatment, while about 45% have not initiated their treatment1, despite providing free of cost HIV testing and treatment services2. The general prevalence of HIV positive drug injectors may reach up to 68,000 in 2020, while specific prevalence may range from 46% to 56% in Karachi and 44% to 50% in Lahore3. HIV-positive injecting drug users (IDUs) in Pakistan incorporate religious rituals into their treatment, including seeking spiritual healing as an alternative to lifelong antiretroviral […]
- [Unraveling the complex interplay: HIV and male infertility](https://aidsreviews.com/en/2025/unraveling-the-complex-interplay-hiv-and-male-infertility-2/): Introduction AIDS, precipitated by the HIV, constitutes a chronic, pernicious condition that profoundly debilitates the immune system, thereby heightening vulnerability to opportunistic infections and specific malignancies. The advent of antiretroviral therapy (ART) has significantly mitigated AIDS-related mortality and substantially prolonged the life expectancy of those afflicted, effectively transmuting AIDS from a fatal affliction into a manageable chronic ailment1. The World Health Organization has articulated ambitious benchmarks to ensure that 90% of individuals achieving viral suppression can sustain a healthy existence. Despite these therapeutic strides, HIV infection persists in exerting deleterious effects on reproductive health, with empirical evidence delineating a robust […]
- [Human ecology: a bridge between medical ethics and the 2030 Agenda](https://aidsreviews.com/en/2025/human-ecology-a-bridge-between-medical-ethics-and-the-2030-agenda/): Introduction There is a close relationship between ecology and bioethics. Ecology describes the life of ecosystems, and bioethics the moral conduct of man. Both the external nature and the person have a created value, and they are subjects of rights and duties. However, only the human being can transform the rest of creation. In this dynamic and evolutionary interrelationship, the precautionary principle should guide human actions: not everything that can be done (science) must be done (ethics). In an unprecedented way, more than 200 scientific journals simultaneously have published an article signed by directors of publishing groups and medical institutions […]
- [Lenacapavir – a strong weapon to accelerate HIV prevention](https://aidsreviews.com/en/2025/lenacapavir-a-strong-weapon-to-accelerate-hiv-prevention/): Introduction Due to the lack of progress on prevention, the global number of new infections is not declining fast enough. In three regions of the world, the numbers of new HIV infections are rising1. Globally, the 2025 prevention target, that is, 95% of people at risk of HIV infection having access to and using effective prevention options (condoms, harm reduction services for people who inject drugs, voluntary medical male circumcision in eastern and southern Africa, and pre-exposure prophylaxis [PrEP]), is not within reach. Condom use remains the most effective low-cost HIV prevention method. The only current technology that offers triple […]
- [Is the HIV-2 pandemic vanishing?](https://aidsreviews.com/en/2025/is-the-hiv-2-pandemic-vanishing/): The first AIDS patients were diagnosed in 1981 in California. Most were white men having sex with men. The causative agent could not be isolated until 1983. It was a retrovirus, human immunodeficiency virus (HIV)-1. By then, AIDS had already spread to almost every continent, and the patients were of all ethnicities. AIDS was also present in women and children. In most cases, there was a history of drug addiction, transfusions, sexually transmitted infections, etc. In 1985, the first HIV diagnostic tests were marketed, which were blood antibody tests. By the mid-80s, there were many HIV-positive people in sub-Saharan Africa, […]
- [Breaking HIV stigma: the role of communication and treatment adherence in the mental health of injected drug users in Pakistan](https://aidsreviews.com/en/uncategorized/breaking-hiv-stigma-the-role-of-communication-and-treatment-adherence-in-the-mental-health-of-injected-drug-users-in-pakistan/)
- [HIV prevalence and its association with cervical cancer risk in southern Africa: a systematic review and meta-analysis](https://aidsreviews.com/en/2025/hiv-prevalence-and-its-association-with-cervical-cancer-risk-in-southern-africa-a-systematic-review-and-meta-analysis/): Introduction HIV infection and cervical cancer are major public health challenges worldwide, particularly in regions where HIV is endemic1,2. Cervical cancer, one of the most common cancers among women, causes significant loss of life, especially in developing countries where access to preventive care and screening remains limited3. According to the World Health Organization4, approximately 660,000 new cases of cervical cancer are diagnosed each year, resulting in over 350,000 deaths. Southern Africa, mainly affected by this disease, experiences a high mortality rate due to the lack of large-scale screening programs and the high prevalence of co-infections, which are major risk factors […]
- [Immunopathology and therapeutic strategies for long COVID: mechanisms, manifestations, and clinical implications](https://aidsreviews.com/en/2025/immunopathology-and-therapeutic-strategies-for-long-covid-mechanisms-manifestations-and-clinical-implications/)
- [HIV/AIDS in Pakistan - progress, barriers, and future directions](https://aidsreviews.com/en/2025/hiv-aids-in-pakistan-progress-barriers-and-future-directions/)
- [Simplification of antiretroviral therapy: comparative review of two-drug and three-drug regimens in HIV treatment](https://aidsreviews.com/en/2025/simplification-of-antiretroviral-therapy-comparative-review-of-two-drug-and-three-drug-regimens-in-hiv-treatment/)
- [Castleman's disease: one disease, multiple etiologies](https://aidsreviews.com/en/2024/castlemans-disease-one-disease-multiple-etiologies/)
- [The burden of HIV-1 and HIV-2 epidemics in Ivory Coast](https://aidsreviews.com/en/2024/the-burden-of-hiv-1-and-hiv-2-epidemics-in-ivory-coast/)
- [Acquired syphilis in the context of pre-exposure prophylaxis for HIV: a systematic review of the scientific literature](https://aidsreviews.com/en/2024/acquired-syphilis-in-the-context-of-pre-exposure-prophylaxis-for-hiv-a-systematic-review-of-the-scientific-literature/)
- [Behavioral interventions for tobacco use in HIV-infected smokers: systematic review and pairwise, network meta-analysis of randomized trials](https://aidsreviews.com/en/2024/behavioral-interventions-for-tobacco-use-in-hiv-infected-smokers-systematic-review-and-pairwise-network-meta-analysis-of-randomized-trials/)
- [Adherence to antiretroviral therapy among HIV-1 patients from sub-Saharan Africa: a systematic review](https://aidsreviews.com/en/2024/adherence-to-antiretroviral-therapy-among-hiv-1-patients-from-sub-saharan-africa-a-systematic-review/)
- [In <i>silico</i> drug repurposing approach to predict most effective HAART for HIV drug resistance variants prevalent in the Indian HIV-positive population](https://aidsreviews.com/en/2024/in-silico-drug-repurposing-approach-to-predict-most-effective-haart-for-hiv-drug-resistance-variants-prevalent-in-the-indian-hiv-positive-population/)
- [Playing catching up: Proceedings of the 1st Spanish conference on genomic medicine](https://aidsreviews.com/en/2024/playing-catching-up-proceedings-of-the-1st-spanish-conference-on-genomic-medicine/)
- [HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review](https://aidsreviews.com/en/2024/hiv-1-resistance-and-virological-failure-to-treatment-with-the-integrase-inhibitors-bictegravir-cabotegravir-and-dolutegravir-a-systematic-literature-review/)
- [HTLV-1/2 infection in Italy: a narrative review of epidemiological studies](https://aidsreviews.com/en/2024/htlv-1-2-infection-in-italy-a-narrative-review-of-epidemiological-studies/)
- [HIV infection and esophageal cancer in Sub-Saharan Africa: a comprehensive meta-analysis](https://aidsreviews.com/en/2024/hiv-infection-and-esophageal-cancer-in-sub-saharan-africa-a-comprehensive-meta-analysis/)
- [Risk factors and mortality outcomes of COVID-19 in people living with HIV: a systematic review and meta-analysis](https://aidsreviews.com/en/2024/risk-factors-and-mortality-outcomes-of-covid-19-in-people-living-with-hiv-a-systematic-review-and-meta-analysis/)
- [Early and contemporary drivers of the HIV-1 group M pandemic](https://aidsreviews.com/en/2024/early-and-contemporary-drivers-of-the-hiv-1-group-m-pandemic/)
- [Comparison on treatment outcomes of patients enrolled on anti-retroviral therapy at different levels of the health-care system in a high HIV/AIDS setting](https://aidsreviews.com/en/2023/comparison-on-treatment-outcomes-of-patients-enrolled-on-anti-retroviral-therapy-at-different-levels-of-the-health-care-system-in-a-high-hiv-aids-setting/)
- [Prevalence and risk factors for HIV infection in truck drivers: a systematic review of global evidence](https://aidsreviews.com/en/2023/prevalence-and-risk-factors-for-hiv-infection-in-truck-drivers-a-systematic-review-of-global-evidence/)
- [The impact of the M184V resistance mutation on treatment outcomes in patients with HIV infection: a systematic review and meta-analysis](https://aidsreviews.com/en/2023/the-impact-of-the-m184v-resistance-mutation-on-treatment-outcomes-in-patients-with-hiv-infection-a-systematic-review-and-meta-analysis/)
- [Rebound in sexually transmitted infections after the COVID-19 pandemic](https://aidsreviews.com/en/2023/rebound-in-sexually-transmitted-infections-after-the-covid-19-pandemic/)
- [Systematic review and meta-analysis of the global prevalence of sexually transmitted infections in people living with HIV and associated risk factors](https://aidsreviews.com/en/2023/systematic-review-and-meta-analysis-of-the-global-prevalence-of-sexually-transmitted-infections-in-people-living-with-hiv-and-associated-risk-factors/)
- [The use of "sex" and "gender" in medical research](https://aidsreviews.com/en/2023/the-use-of-sex-and-gender-in-medical-research/)
- [The use of the brief symptom inventory among youth living with HIV: a scoping review](https://aidsreviews.com/en/2023/the-use-of-the-brief-symptom-inventory-among-youth-living-with-hiv-a-scoping-review/)
- [Association between genital mycoplasmas (<i>Ureaplasma urealyticum and Mycoplasma hominis</i>) and HIV infection: a systematic review and meta-analysis](https://aidsreviews.com/en/2023/association-between-genital-mycoplasmas-ureaplasma-urealyticum-and-mycoplasma-hominis-and-hiv-infection-a-systematic-review-and-meta-analysis/)
- [HIV patients� bone loss before and after antiretroviral treatment and its possible mechanisms](https://aidsreviews.com/en/2023/hiv-patients%ef%bf%bd-bone-loss-before-and-after-antiretroviral-treatment-and-its-possible-mechanisms/)
- [Antiretroviral therapy and weight gain in antiretroviral treatment-experienced HIV patients: A review](https://aidsreviews.com/en/2023/antiretroviral-therapy-and-weight-gain-in-antiretroviral-treatment-experienced-hiv-patients-a-review/)
- [The new profile of psychiatric disorders in patients with HIV infection](https://aidsreviews.com/en/2023/the-new-profile-of-psychiatric-disorders-in-patients-with-hiv-infection/)
- [The management of polypharmacy in people living with HIV](https://aidsreviews.com/en/2023/the-management-of-polypharmacy-in-people-living-with-hiv/)
- [Weight gain in HIV-infected patients](https://aidsreviews.com/en/2023/weight-gain-in-hiv-infected-patients/)
- [Viral hepatitis in persons living with HIV in the post-COVID era](https://aidsreviews.com/en/2023/viral-hepatitis-in-persons-living-with-hiv-in-the-post-covid-era/)
- [Is SARS-CoV-2 the only cause of long-COVID?](https://aidsreviews.com/en/2022/is-sars-cov-2-the-only-cause-of-long-covid/)
- [Unraveling the complex interplay: HIV and male infertility](https://aidsreviews.com/en/uncategorized/unraveling-the-complex-interplay-hiv-and-male-infertility/)
- [Rising in Listeria monocytogenes infection - any risk for persons living with HIV?](https://aidsreviews.com/en/2025/rising-in-listeria-monocytogenes-infection-any-risk-for-persons-living-with-hiv/)
- [Antiretroviral therapy and weight gain in naive HIV-1 infected patient: a narrative review](https://aidsreviews.com/en/2022/antiretroviral-therapy-and-weight-gain-in-naive-hiv-1-infected-patient-a-narrative-review/)
- [The spectrum of infectious pathogens in patients with primary or secondary immunodeficiency](https://aidsreviews.com/en/2025/the-spectrum-of-infectious-pathogens-in-patients-with-primary-or-secondary-immunodeficiency/)
- [HIV and aging, biological mechanisms, and therapies: What do we know?](https://aidsreviews.com/en/2022/hiv-and-aging-biological-mechanisms-and-therapies-what-do-we-know/)
- [HIV-1 infection and the hematopoietic microenvironment](https://aidsreviews.com/en/2024/hiv-1-infection-and-the-hematopoietic-microenvironment/)
- [Sexually transmitted infections keep rising up](https://aidsreviews.com/en/2024/sexually-transmitted-infections-keep-rising-up/)
- [Humanized mouse models for preclinical evaluation of HIV cure strategies](https://aidsreviews.com/en/2022/humanized-mouse-models-for-preclinical-evaluation-of-hiv-cure-strategies/)
- [Strengthen the doctor-patient relationship and avoid administrative stifling](https://aidsreviews.com/en/2024/strengthen-the-doctor-patient-relationship-and-avoid-administrative-stifling/)
- [Oral antivirals for the prevention and treatment of SARS-CoV-2 infection](https://aidsreviews.com/en/2022/oral-antivirals-for-the-prevention-and-treatment-of-sars-cov-2-infection/)
- [On the origin of life on earth](https://aidsreviews.com/en/2024/on-the-origin-of-life-on-earth/)
- [International HTLV Conference, London, June 3-5, 2024](https://aidsreviews.com/en/2024/international-htlv-conference-london-june-3-5-2024/)
- [Risk factors associated with pulmonary arterial hypertension among HIV-infected adults: A meta-analysis and systematic review](https://aidsreviews.com/en/2022/risk-factors-associated-with-pulmonary-arterial-hypertension-among-hiv-infected-adults-a-meta-analysis-and-systematic-review/)
- [HTLV in Sweden](https://aidsreviews.com/en/2024/htlv-in-sweden/)
- [Mobile applications in HIV self-management: A systematic review of scientific literature](https://aidsreviews.com/en/2022/mobile-applications-in-hiv-self-management-a-systematic-review-of-scientific-literature/)
- [HIV/HBV coinfection: understanding the complex interactions and their impact on spontaneous HBV clearance, chronic liver damage, cirrhosis, and hepatocellular carcinoma](https://aidsreviews.com/en/2024/hiv-hbv-coinfection-understanding-the-complex-interactions-and-their-impact-on-spontaneous-hbv-clearance-chronic-liver-damage-cirrhosis-and-hepatocellular-carcinoma/)
- [Dolutegravir in Mexico for special populations: A cost analysis perspective](https://aidsreviews.com/en/2021/dolutegravir-in-mexico-for-special-populations-a-cost-analysis-perspective/)
- [Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals](https://aidsreviews.com/en/2023/pre-exposure-prophylaxis-of-non-hiv-viral-infections-and-the-role-of-long-acting-antivirals/)
- [The prevalence of HIV-infected patients with virological suppression but a CD4<sup>+</sup> T-cell count of ? 200 cells/mm<sup>3</sup> after highly active antiretroviral therapy initiation: A meta-analysis](https://aidsreviews.com/en/2022/the-prevalence-of-hiv-infected-patients-with-virological-suppression-but-a-cd4-t-cell-count-of-200-cells-mm3-after-highly-active-antiretroviral-therapy-initiation-a-meta-analysis/)
- [HTLV European Research Network 2023: the silent pandemic of HTLV-1 infection](https://aidsreviews.com/en/2023/htlv-european-research-network-2023-the-silent-pandemic-of-htlv-1-infection/)
- [Mitochondrial damage as cause of long COVID](https://aidsreviews.com/en/2023/mitochondrial-damage-as-cause-of-long-covid/)
- [Sarcopenia in persons living with HIV under antiretroviral therapy: Literature review](https://aidsreviews.com/en/2022/sarcopenia-in-persons-living-with-hiv-under-antiretroviral-therapy-literature-review/)
- [Mental Health Crisis in the Youth and Rebound in Sexually Transmitted Infections](https://aidsreviews.com/en/2023/mental-health-crisis-in-the-youth-and-rebound-in-sexually-transmitted-infections/)
- [Coinfection with Viral Hepatitis in HIV patients in 2023](https://aidsreviews.com/en/2023/coinfection-with-viral-hepatitis-in-hiv-patients-in-2023/)
- [Safety of Antiretroviral Therapy in the Treatment of HIV/AIDS in Children: Systematic Review and Meta-analysis](https://aidsreviews.com/en/2021/safety-of-antiretroviral-therapy-in-the-treatment-of-hiv-aids-in-children-systematic-review-and-meta-analysis/)
- [COVID-19 vaccination in people living with HIV: current data and perspectives](https://aidsreviews.com/en/2022/covid-19-vaccination-in-people-living-with-hiv-current-data-and-perspectives/)
- [Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients](https://aidsreviews.com/en/2021/differentials-of-sars-cov-2-viral-rna-re-positivity-in-discharged-covid-19-patients/)
- [The role of nurses in the prevention of anal cancer in HIV-infected men having sex with men - a focus on papillomavirus vaccination and anal cytology screening](https://aidsreviews.com/en/2022/the-role-of-nurses-in-the-prevention-of-anal-cancer-in-hiv-infected-men-having-sex-with-men-a-focus-on-papillomavirus-vaccination-and-anal-cytology-screening/)
- [Efficacy and Safety of Triple versus Dolutegravir-based Dual Therapy in Patients with HIV-1 Infection: A Meta-analysis of Randomized Controlled Trials](https://aidsreviews.com/en/2021/efficacy-and-safety-of-triple-versus-dolutegravir-based-dual-therapy-in-patients-with-hiv-1-infection-a-meta-analysis-of-randomized-controlled-trials/)
- [Sarcopenia in people living with HIV. A review](https://aidsreviews.com/en/2022/sarcopenia-in-people-living-with-hiv-a-review/)
- [News from CROI 2022 - caveats using antiretrovirals as HIV prophylaxis](https://aidsreviews.com/en/2022/news-from-croi-2022-caveats-using-antiretrovirals-as-hiv-prophylaxis/)
- [A systematic review and meta-analysis to estimate the time from HIV infection to diagnosis for people with HIV](https://aidsreviews.com/en/2022/a-systematic-review-and-meta-analysis-to-estimate-the-time-from-hiv-infection-to-diagnosis-for-people-with-hiv/)
- [A cure for HIV on the horizon](https://aidsreviews.com/en/2022/a-cure-for-hiv-on-the-horizon/)
- ["Moving Fourth": Introduction of a practical toolkit for shared decision-making to facilitate healthy living beyond HIV viral suppression](https://aidsreviews.com/en/2021/moving-fourth-introduction-of-a-practical-toolkit-for-shared-decision-making-to-facilitate-healthy-living-beyond-hiv-viral-suppression/)
- [HIV and liver disease](https://aidsreviews.com/en/2022/hiv-and-liver-disease/)
- [Study of Quality of Life and Depression in People Living with HIV/AIDS in India](https://aidsreviews.com/en/2021/study-of-quality-of-life-and-depression-in-people-living-with-hiv-aids-in-india/)
- [International outbreak of monkeypox in men having sex with men](https://aidsreviews.com/en/2022/international-outbreak-of-monkeypox-in-men-having-sex-with-men/)
- [Smoking among people living with HIV/AIDS: a bibliometric analysis (GAP <sub>RESEARCH</sub>)](https://aidsreviews.com/en/2022/smoking-among-people-living-with-hiv-aids-a-bibliometric-analysis-gap-research/)
- [Research progress on HIV-1 immune escape mechanisms](https://aidsreviews.com/en/2022/research-progress-on-hiv-1-immune-escape-mechanisms/)
- [Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?](https://aidsreviews.com/en/2021/is-intermittent-antiretroviral-therapy-a-satisfactory-strategy-for-the-management-of-patients-living-with-hiv/)
- [Malignancies in people living with HIV](https://aidsreviews.com/en/2022/malignancies-in-people-living-with-hiv/)
- [A greater virulent HIV-1 subtype B variant has circulated in The Netherlands since the 1990’s](https://aidsreviews.com/en/2022/a-greater-virulent-hiv-1-subtype-b-variant-has-circulated-in-the-netherlands-since-the-1990%c2%92s/)
- [Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status](https://aidsreviews.com/en/2021/current-situation-and-prospect-of-hiv-associated-neurocognitive-disorder-research-in-china-epidemiology-research-diagnosis-and-treatment-status/)
- [Relationship between cytokine storm and SARS-CoV-2 infection's worsening](https://aidsreviews.com/en/2022/relationship-between-cytokine-storm-and-sars-cov-2-infections-worsening/)
- [A Systematic Review of Magnetic Resonance Imaging Studies in Perinatally HIV-Infected Individuals](https://aidsreviews.com/en/2021/a-systematic-review-of-magnetic-resonance-imaging-studies-in-perinatally-hiv-infected-individuals/)
- [Determinants of natural HIV-1 control](https://aidsreviews.com/en/2022/determinants-of-natural-hiv-1-control/)
- [The opioid epidemic during the COVID-19 pandemic: Impact on HIV and HCV control](https://aidsreviews.com/en/2021/the-opioid-epidemic-during-the-covid-19-pandemic-impact-on-hiv-and-hcv-control/)
- [How Does HIV Persist Under Antiretroviral Therapy: A Review of the Evidence](https://aidsreviews.com/en/2021/how-does-hiv-persist-under-antiretroviral-therapy-a-review-of-the-evidence/)

## Pages

- [Mi cuenta](https://aidsreviews.com/en/mi-cuenta/)
- [Finalizar compra](https://aidsreviews.com/en/finalizar-compra/)
- [Carrito](https://aidsreviews.com/en/carrito/): Remove item Thumbnail image Product Price Quantity Subtotal &times; Acceso: HIV/AIDS in Pakistan &#8211; progress, barriers, and future directions&nbsp; 36,30&nbsp;&euro; Acceso: HIV/AIDS in Pakistan &#8211; progress, barriers, and future directions quantity 36,30&nbsp;&euro; Totals Subtotal 36,30&nbsp;&euro; Total 36,30&nbsp;&euro; Proceed to Checkout
- [Tienda](https://aidsreviews.com/en/tienda/)
- [TOC Alert - Confirmación / Confirmation](https://aidsreviews.com/es/toc-alert-conf/): Gracias, la suscripción ha sido activada con éxito.Thank you, the subscription has been successfully activated.
- [Data Protection Policy](https://aidsreviews.com/en/data-protection-policy/): DATA PROTECTION POLICYThis is the data protection policy of PUBLICIDAD PERMANYER SL. It refers to data processing in the exercise of its editorial activities in compliance with the General Data Protection Regulation (Regulation (EU) 2016/679 of the European Parliament and of the Council, of April 27, 2016).Who is responsible for the processing of personal data?The party responsible for the processing of personal data is PUBLICIDAD PERMANYER SL (hereinafter PUBLICIDAD PERMANYER), with CIF (Tax Identification Code) B08327512, headquartered at Calle Mallorca 310, 08037 Barcelona, telephone 93 207 59 20, email: permanyer@permanyer.com, www.permanyer.com. The Company is registered at the Board of Trade [&hellip;]
- [Política de protección de datos](https://aidsreviews.com/es/politica-de-proteccion-de-datos/): Esta es la política de protección de datos de PUBLICIDAD PERMANYER SL. Hace referencia a los datos que trata en el ejercicio de sus actividades editoriales dando cumplimiento al Reglamento General de Protección de Datos (Reglamento (UE) 2016/679 del Parlamento Europeo y del Consejo, de 27 de abril de 2016).¿Quién es el responsable del tratamiento de los datos personales?El responsable del tratamiento de los datos personales es PUBLICIDAD PERMANYER SL (en adelante PUBLICIDAD PERMANYER), con CIF B08327512, domicilio en calle Mallorca, 310, 08037 Barcelona, teléfono 93 207 5920, correo electrónico permanyer@permanyer.com, www.permanyer.com. Figura inscrita en el Registro Mercantil de Barcelona, [&hellip;]
- [Permissions & Reprints](https://aidsreviews.com/en/permissions-reprints/): Reusing content1.- To request a quote for reprinting or translatingThe language in which the article is to be printed.Option: Personalization of your reprints by adding your company logo or advertisement (key positions to be defined).For a personalized offer, please contact: permanyer@permanyer.com, including the following information:Details of the journal, title, publication year, issue and page numbers.The language in which the article is to be printed.Number of copies.Full contact details, including an e-mail address and phone number.2.- To request permission for other reuse contentPlease provide citation details.The language in which the reuse content is to be printed.For a personalized offer, please contact: [&hellip;]
- [Permisos y reimpresiones](https://aidsreviews.com/es/permisos-y-reimpresiones/): Utilización de Contenidos1.- Solicitud de reprints o traducciones:En el mismo idioma de la publicación o traducido a cualquier idioma.Opción de personalizar el reprint con el logo de su Compañía o publicidad (espacios a determinar).Para recibir presupuesto contactar a permanyer@permanyer.com incluyendo la siguiente información:Referencia bibliográfica completa (publicación, autor, título, volumen, páginas).Idioma en el que desea los reprints.Número de ejemplares.Contacto: empresa, persona de contacto, correo electrónico, teléfono.2.- Solicitud de AutorizacionesPara reproducir partes de un artículo (tablas, figuras, etc.).En el mismo idioma o traducido a cualquier idioma.Para recibir autorización y/o presupuesto contactar a permanyer@permanyer.com incluyendo:Información completa del material que desea utilizar (artículo completo, [&hellip;]
- [Legal notice and data protection policy](https://aidsreviews.com/en/legal-notice/): AIDS Reviews is a publication edited by Permanyer España, S.A. de C.V., located at Mallorca Street, 310, 08037 Barcelona, Spain. This website and the domain lccrjournal.com are managed by Permanyer España, S.A. de C.V.Access to and use of the AIDS Reviews website implies acceptance of the following conditions.Intellectual and Industrial PropertyThe contents presented through this website—such as (for example) layout, design, texts, images, graphics, headers, logos, and other distinctive signs—are the exclusive property of Permanyer España, S.A. de C.V. These contents are protected under intellectual and industrial property laws. Prior written authorization from Permanyer España, S.A. de C.V. is required to use [&hellip;]
- [Aviso legal](https://aidsreviews.com/es/aviso-legal/): Anales Médicos es una publicación editada por Permanyer México, S.A. de C.V., con RFC PME120130CM8, domiciliada en calle Arquímedes 190, interior 404 &#8211; Col. Polanco, Deleg. Miguel Hidalgo, C.P. 11560 – Ciudad de México.Este sitio web y el dominio www.analesmedicosabc.com son gestionados por Permanyer México, S.A. de C.V.El acceso y uso del sitio web de Anales Médicos comporta la aceptación de las siguientes condiciones.Propiedad intelectual e industrialLos contenidos que se presenten por medio de este sitio web, como son (enumeración indicativa) la composición, el diseño, los textos, las imágenes, los gráficos, los encabezamientos, los logotipos y otros signos distintivos, son [&hellip;]
- [Ejemplo EN](https://aidsreviews.com/en/ejemplo-en/): This is a test
- [Ejemplo ES](https://aidsreviews.com/es/ejemplo/): Esto es un ejemplo
- [Toc Alert](https://aidsreviews.com/en/toc-alert-2/): TOC ALERT allows you to be automatically notified when a new issue of the journal is published.
- [Authors](https://aidsreviews.com/en/authors/)
- [Ahead of print](https://aidsreviews.com/en/ahead-of-print/)
- [Editorial &amp; Peer review](https://aidsreviews.com/en/editorial-peer-review/): The journal uses double blind peer review (neither the author nor the reviewer knows each other’s identity).The editorial process comprises 7 steps:1. Review by editorial officeUpon reception of the manuscript, the editorial office reviews the document to ensure adhesion to author guidelines (format, style, sections, references, etc.), which are available at the journal website.2. Review by the editor in chiefThe editor in chief reviews the manuscript, and validates if the theme, originality and scientific quality of the paper are fit to be published in the journal.The manuscript is evaluated for plagiarism, double publication and related issues.The manuscript may be rejected [&hellip;]
- [Procedure for complaints and/or appeals](https://aidsreviews.com/en/procedure-for-complaints-and-or-appeals/): This procedure is related to complaints about policy, procedure or actions from the editorial staff of the journal. The journal’s editorial staff is open to comments and complaints that contribute to the improvement of our processes. We are committed to answer such complaints in an expedite and constructive manner. The procedure to file a complaint is as follows:The individual that files a complaint must do so via the following email address: permanyer@permanyer.comA complaint must be related to an error in the editorial procedure, such as a disproportionately long delay in replying to an author or reaching a decision regarding a [&hellip;]
- [Sponsors](https://aidsreviews.com/en/sponsors/): Some issues of the Journal may have sponsor advertisements.However, sponsors are not involved in any way in the selection or editing of published content.The editorial and scientific committees of the journal are independent of commercial sponsors.  
- [Journal Information](https://aidsreviews.com/en/journal-information/): MissionAIDS Reviews is committed to disseminating high-quality scientific knowledge in the field of HIV infection, epidemiology, and its comorbidities, providing critical, up-to-date, and rigorous reviews that contribute to clinical practice, biomedical research, and public health policies worldwide.VisionTo become the leading international journal in English on HIV/AIDS, epidemiology, and related global health issues, recognized for its methodological quality, editorial independence, and ability to anticipate emerging challenges in research, clinical care, and prevention.Main objectiveTo consolidate a prestigious international editorial platform that fosters the continuous scientific advancement of healthcare professionals, researchers, and policymakers, promoting critical reflection and knowledge exchange on HIV/AIDS, epidemiology, and [&hellip;]
- [Funding](https://aidsreviews.com/en/funding/): For publication in AIDS Reviews, authors are required to pay an Article Processing Charge (APC) once the manuscript has been accepted following peer review.The standard APC is 500 euros (gross), which covers editorial production and publication costs, and can be paid by credit card or bank transfer. Authors who wish to publish their article under open access may do so by paying an APC of 1,200 euros (gross).Instructions for payment are sent upon the acceptance of the article.Waiver of Fees: The editor may grant a waiver of Article Processing Charges (APC) if the author or their institution is in a [&hellip;]
- [Ethical policies](https://aidsreviews.com/en/ethical-policies/): The journal follows the best practice guidelines described by the Committee on Publication Ethics (COPE). Here we detail briefly all points. For more information, visit please the official website on Core practices from COPE.Protection of people and animalsAll studies that involve data, procedures, treatments, etc. in humans must have written authorization from an ethics committee of the participating institution, which must be attached to the manuscripts submitted on the platform, in addition to following the ethical guidelines of the World Medical Association and the Declaration of Helsinki. available at WMA. Authors must state in the section «Methods» that the procedures [&hellip;]
- [Contact](https://aidsreviews.com/en/contact/): If you need more information about the journal, please contact us:PermanyerMallorca, 31008037 Barcelona (Spain)permanyer@permanyer.comEditor jefeVicente SorianoEditor-in-Chief
- [Open access &amp; Licensing](https://aidsreviews.com/en/open-access-licensing/): All articles published in AIDS Reviews are subject to a 6-month embargo period, after which they are distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).During the embargo, content is accessible exclusively to subscribers or through pay-per-view. Once the 6-month embargo has expired, articles become freely available to all readers. At that point, readers may read, download, copy, distribute, print, search, link to the full texts, or use the articles for any other lawful purpose, without prior permission from the publisher (Publicaciones Permanyer) or the authors, provided that the use is non-commercial, the content [&hellip;]
- [Editorial Polices](https://aidsreviews.com/en/editorial-polices/): AIDS Reviews is governed according to the following policies:The journal will have a unique name and design, it will have publication licenses (including Creative Commons), national and international indexing, ISSN and current registration. It will have a secure website.Scientific manuscripts on HIV/AIDS and epidemiology, of national and international origin and interest, in English, including studies with negative results that adhere to the international recommendations of good practices, will be evaluated.– World Health Organization: https://www.who.int/about/policies/publishing/open-access– Plan S: https://www.coalition-s.org/plan_s_principles/a– International Committee of Medical Journal Editors: https://www.icmje.org/icmje-recommendations.pdf– COPE Core practices: https://publicationethics.org/core-practices– REWARD: https://www.thelancet.com/campaigns/efficiency/statement– EQUATOR (Enhancing the QUAlity and Transparency Of health Research): https://www.equator-network.org/about-us/– Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update. https://www.ismpp.org/gpp-2022#:~:text=GPP%202022%20is%20the%20third,publications%2C%20and%20policies%20and%20proceduresThe submitted manuscripts will [&hellip;]
- [Operations Manual](https://aidsreviews.com/en/operations-manual/): Objective. The purpose of this operating manual is to regulate the organization and operation of AIDS Reviews.Definitions. The following abbreviations are included in this Operations Manual:Publisher: Publicaciones Permanyer Journal: AIDS ReviewsGeneral Terms:These provisions shall be mandatory for everybody involved in the functioning of the Journal, authors, and peer reviewers alike. Publicaciones Permanyer is the proprietor of the Journal, of the rights of the registered trademark, and the corresponding copyrights.Publicaciones Permanyer holds all rights regarding the publication of the Journal. The Journal shall be published quarterly, online, and in English.The content of the Journal will be available as open access to the scientific community, at no expense for the [&hellip;]
- [Authors Instructions](https://aidsreviews.com/en/authors-instructions/): Please consult the Funding section in this website, before submitting a manuscript.Authors are asked to submit manuscripts to one of the following sections of AIDS Reviews: Review articles, and Correspondence.Authors will be asked to send the paper in electronic format and in English. These instructions comply with those formulated by the International Committee of Medical Journal Editors (www.icmje.org). For further details, authors should consult the Uniform requirements for manuscripts submitted to biomedical journals Here.AIDS Reviews publishes papers reporting original scientific, clinical, epidemiologic and social research that contribute to the overall knowledge of the field of AIDS and human retrovirology.Currently, AIDS Reviews publishes [&hellip;]
- [Editorial Board](https://aidsreviews.com/en/editorial-board/): Editor-in-ChiefVincent SorianoMadrid, SpainExecutive EditorPablo BarreiroMadrid, SpainEditorsAnne-Mieke VandammeLeuven, BelgiumWalid HeneineAtlanta, USAGenoveffa FranchiniBethesda, USAEditorial boardSalim Abdool KarimDurban, South AfricaEric ArtsCleveland, USASally BlowerLos Angeles, USAPedro CahnBuenos Aires, ArgentinaFrancesca Ceccherini-SilbersteinRome, ItalyEdward CachaySan Diego, CABonaventura ClotetBarcelona, SpainCalvin CohenBoston, USASteven DeeksSan Francisco, USARicardo DiazSao Paulo, BrazilUrsula DietrichFrankfurt, GermanyMassimo GalliMilan, ItalyHoward E. GendelmanNebraska, USAAnna Maria GerettiLiverpool, UKTakashi GojoboriTokyo, JapanEduardo González-FraileBilbao, SpainAngelos HatzakisAthens, GreeceEric HunterAtlanta, USAJonathan E. KaplanAtlanta, USAChristine KatlamaParis, FranceDaniel KuritzkesBoston, USAShyamasundaran KottililBaltimore, USAKarine LacombeParis, FranceAlain LafeuilladeToulon, FranceAlan LandayChicago, USAJosep M. LlibreBarcelona, SpainJens LundgrenCopenhagen, DenmarkMartin MarkowitzNew York, USAJean-Michel MolinaParis, FranceJulio MontanerVancouver, CanadaRobert MurphyChicago, USAMark NelsonLondon, UKTulio de OliveiraDurban, South AfricaDan OteleaBucharest, RomaniaDimitrios ParaskevisAthens, GreeceCarlo Federico PernoMilan, ItalyDaniel [&hellip;]
- [Code of conduct for reviewers](https://aidsreviews.com/en/code-of-conduct-for-reviewers/): Reviewers for AIDS Reviews  must commit to perform with responsibility, integrity, confidentiality, impartiality, and objectivity, ensuring transparency in their reviews.In any case, potential conflicts of interest must be declared.The reviewers will evaluate the following aspects in the received manuscripts:Originality and academic qualityTimeliness and relevanceScientific contributionAdherence to ethical principlesMethodological qualityTransparencyAny suspicion about the existence of the following criteria must be communicated to the Editor-in-Chief:PlagiarismLack of adherence to international ethical standards in the development of research.Data fractioning or salami slicingFalsification, appropriation, or unauthorized reproduction of data, figures, images, algorithms, or tables.Duplicate or redundant publicationManipulation of bibliographic citations, including unwarranted self-citationOmission of relevant information [&hellip;]
- [Code of conduct for authors](https://aidsreviews.com/en/code-of-conduct-for-authors/): The authors of manuscripts submitted to AIDS Reviews are required to adhere to principles of honesty, integrity, responsibility, and transparency.They must disclose any potential conflict of interest and/or funding, scholarships, or payment of fees from private sector, received within the last 3 years, or during the course of their research.The following actions will be considered bad practices and may lead to the retraction of the manuscript:PlagiarismLack of adherence to international ethical standards in the development of research.Data fractioning or salami slicingFalsification, appropriation, or unauthorized reproduction of data, figures, images, algorithms, or tables.Duplicate or redundant publicationManipulation of bibliographic citations, including unwarranted self-citationOmission of [&hellip;]
- [Autores](https://aidsreviews.com/es/autores/)
- [Publicación adelantada](https://aidsreviews.com/es/publicacion-adelantada/)
- [Comité editorial](https://aidsreviews.com/es/comite-editorial/): DIRECTORAdiel Asch RabinovichDepartamento de Otorrinolaringología, Cirugía de Cabeza y Cuello, Centro Médico ABC Observatorio; Presidente de la Asociación Médica del Centro Médico ABC. Ciudad de México, MéxicoEDITOR EN JEFEMiguel Ángel Collado CoronaServicio de Neurofisiología Clínica, Centro Neurológico,Centro Médico ABC Santa Fe, Ciudad de México, MéxicoCOEDITORESDaniel Bross SorianoServicio de Otorrinolaringologia,Centro Médico ABC Santa Fe, Ciudad de México, MéxicoEmilio Arch Tirado Centro Neurológico,Centro Médico ABC Santa fe, Ciudad de México, MéxicoEDITORES EMÉRITOS   Raquel Gerson CwilichServicio de Oncología Clínica,Centro Médico ABC, Observatorio, Ciudad de México, México.Juan Manuel Fernández VázquezOrtopedia, Traumatología y Cirugía de Mano,Centro Médico ABC Santa Fe, Ciudad de México, México Comité nacional Yuria [&hellip;]
- [TOC Alert](https://aidsreviews.com/es/toc-alert/): TOC ALERT le permitirá ser notificado automáticamente cuando un nuevo número de la revista sea publicado.
- [Home - EN](https://aidsreviews.com/en/): See advanced publications 2025 Journal Impact Factor: 1.9  Advanced publication
- [Contacto](https://aidsreviews.com/es/contacto/): Si usted requiere información acerca de la revista, por favor, contáctenos Permanyer Mallorca, 31008037 Barcelona (España)Temístocles, 315Colonia PolancoDelegación Miguel Hidalgo11560, Ciudad de México, Méxicopermanyer@permanyer.com Editor jefe  Juan Guillermo Corrales RiverosEditor Jefejg1corrales@yahoo.esPermanyerArquímedes, 190 – Colonia PolancoMiguel Hidalgo, 11560,Ciudad de México (México)Mallorca, 31008037 Barcelona (España)permanyer@permanyer.com  Editor jefe / Editor in chiefDr. Miguel Ángel Collado Corona mcollado@prodigy.net.mx
- [Patrocinadores](https://aidsreviews.com/es/patrocinadores/): Algunos números de la revista impresa pueden tener anuncios de patrocinadores.Sin embargo, los patrocinadores no participan de ninguna forma en la selección o edición del contenido publicado. El comité editorial de la revista es independiente de los patrocinadores comerciales.  
- [Acceso abierto y Licencia](https://aidsreviews.com/es/acceso-abierto-y-licencia/): La revista apoya firmemente la iniciativa de acceso abierto (sin pago para publicar ni leer) y usa la licencia de uso abierto Creative Commons Attribution License (CC BY-NC-ND 4.0). Es una revista de acceso abierto, que quiere decir que todo el contenido está disponible de forma gratuita a todos los usuarios y sus instituciones. Cualquier usuario puede leer, descarga, copiar, distribuir, imprimir, buscar, ligar al texto completo de cualquiera de los artículos o cualquier otro uso lícito, sin necesidad de pedir permiso al autor, a la Sociedad o editorial, siempre que sea para uso no comercial, no modifique la obra [&hellip;]
- [Procedimiento para quejas y apelaciones](https://aidsreviews.com/es/procedimiento-para-quejas-y-apelaciones/): Este procedimiento se aplica a las quejas sobre las políticas, procedimientos o acciones del personal editorial de la revista. El personal editorial de la revista esta abierto a recibir todas las quejas que les permitan ser más justos y mejorar los procesos, y comprometidos en responder de forma rápida y constructivamente.El procedimiento para realizar una queja se describe a continuación:Todas las quejas deberán enviarse a la siguiente dirección: permanyer@permanyer.comLas quejas deben estar relacionadas con un error en el procedimiento editorial, como por ejemplo una gran demora, una respuesta grosera o un grave error de juicio.La queja debe ser sobre algo [&hellip;]
- [Fuentes de ingreso](https://aidsreviews.com/es/fuentes-de-ingreso/): Anales Médicos es el órgano oficial de difusión científica de la Asociación Médica del Centro Médico ABC., siendo ésta la fuente principal de financiamiento de la revista.La revista apoya firmemente la iniciativa de acceso abierto, no realiza cargos económicos por la producción ni publicación de los artículos y todos los artículos son publicados en abierto sin coste para los lectores bajo los términos de la licencia Creative Commons Attribution License (CC BY-NC-ND 4.0).
- [Ética editorial](https://aidsreviews.com/es/etica-editorial/): La revista sigue el código de buenas prácticas descrito por el Committee on Publication Ethics (COPE). A continuación, se detallan brevemente todos los puntos. Para más información por favor, visite la página oficial en Core practices en COPE.Protección de personas y animalesTodos los estudios que involucren datos, maniobras, tratamientos, etc., en humanos, deberán de contar con la autorización por escrito de un comité de ética de la institución participante, el cual debe ser anexado a los papeles sometidos en la plataforma, además de seguir las norma éticas de la Asociación Médica Mundial y la Declaración de Helsinki disponible en: http://www.wma.net/. Los autores [&hellip;]
- [Proceso de revisión](https://aidsreviews.com/es/proceso-de-revision/): La revista utiliza una revisión por pares doble ciego (la identidad del autor y revisor es anónima respectivamente).El proceso de revisión se divide en 7 pasos principales: 1. Revisión por parte de la oficina editorial:Una vez que se somete el artículo, la oficina editorial revisa el documento para que cumpla las guías para los autores (formato y estilo del documento, secciones, bibliografía, etc.) disponibles en la web de la revista.2. Revisión por el editor jefe de la revista:El editor jefe revisa el documento y valida si la temática, originalidad y calidad científica es adecuada para continuar el proceso y poder [&hellip;]
- [Código de conducta para autores](https://aidsreviews.com/es/codigo-de-conducta-para-autores/): Los autores de manuscritos enviados a Anales Médicos se comprometen a seguir los principios de honestidad, integridad, responsabilidad y transparencia. En cualquier caso, deberán declarar cualquier potencial conflicto de intereses y/o financiamiento, beca o pago de honorarios por la iniciativa privada recibidos en los últimos 3 años, o durante el desarrollo de su investigación.  Las siguientes acciones se considerarán malas prácticas y podrán conllevar a la retracción del manuscrito: PlagioFalta de apego los estándares éticos internacionales en el desarrollo de la investigaciónFraccionamiento de datos o salami slicingFalsificación, apropiación, o reproducción no autorizada por parte del autor intelectual de datos, figuras, imágenes, [&hellip;]
- [Código de conducta para revisores](https://aidsreviews.com/es/codigo-de-conducta-para-revisores/): Los revisores de manuscritos de Anales Médicos se comprometen a observar los siguientes preceptos: Confidencialidad Cordialidad Oportunidad Objetividad Imparcialidad Responsabilidad Integridad Justicia En todo caso se deberá declarar posibles conflictos de intereses. Los editores deben tener en cuenta que la utilización de inteligencia artificial para la revisión de manuscritos puede suponer una violación a los términos de confidencialidad. Los revisores deberán solicitar autorización del editor jefe si desean emplear herramientas de inteligencia artificial para revisar manuscritos.Para más información: ICMJE: Use of artificial intelligence in the review process Evaluará el manuscrito de acuerdo con su: Originalidad Actualidad Relevancia Claridad Transparencia Pertinencia Aportación científica Apego a principios éticos Calidad metodológica Deberá reportar al/la editor(a) cualquier sospecha de mala conducta por parte de los [&hellip;]
- [Instrucciones para autores](https://aidsreviews.com/es/instrucciones-para-autores/): Anales Médicos es el órgano oficial de difusión de la Asociación Médica del Centro Médico ABC. Anales Médicos recibe manuscritos de investigación original e inédita, de revisión, e informes de casos clínicos, así como cartas al editor que contribuyan a enriquecer el conocimiento y desarrollo de los aspectos clínicos, epidemiológicos y básicos de la medicina, provenientes de todas las fuentes y de todos los países. También recibe manuscritos enviados por autores con especialidades o materias relacionadas con la medicina.Anales Médicos se publica con periodicidad trimestral (cuatro números por año), en formato impreso y electrónico con acceso abierto (gratuito para autores y [&hellip;]
- [Políticas editoriales](https://aidsreviews.com/es/politicas-editoriales/): Anales Médicos se rige de acuerdo con las siguientes políticas:La revista tendrá un nombre y diseño único, contará con licencias de publicación (incluida Creative Commons), indización nacional e internacional, ISSN y registro vigente ante INDAUTOR. Contará con un sitio electrónico seguro.Se evaluarán manuscritos científicos en el área de la medicina, de procedencia nacional e internacional, en español o inglés y estudios con resultados negativos, que se apeguen a las recomendaciones internacionales de buenas prácticas.– Acceso abierto– World Health Organization: https://www.who.int/about/policies/publishing/open-access  – Plan S: https://www.coalition-s.org/plan_s_principles/    – International Committee of Medical Journal Editors: https://www.icmje.org/icmje-recommendations.pdf– COPE Core practices: https://publicationethics.org/core-practices  – REWARD: https://www.thelancet.com/campaigns/efficiency/statement  – EQUATOR (Enhancing the QUAlity and Transparency Of [&hellip;]
- [Manual de operaciones](https://aidsreviews.com/es/manual-de-operaciones/): Objetivo. El presente manual de operación tiene como objeto regular la organización y operación de la revista Anales Médicos. Definiciones. Para los efectos del presente manual de operaciones, se entenderá por:&#8211; Asociación Médica del Centro Médico ABC&#8211; Editorial: Publicaciones Permanyer &#8211; Revista: Anales MédicosTérminos generales• Los siguientes criterios son de seguimiento obligatorio para toda persona involucrada en el funcionamiento de la Revista, autores y revisores pares. • La Asociación Médica del Centro Médico ABC es propietario de la Revista, de los derechos de la marca comercial y de los derechos de autor correspondientes.• Durante la vigencia del convenio suscrito entre la Asociación Médica [&hellip;]
- [Información de la revista](https://aidsreviews.com/es/informacion-de-la-revista/): ISSN: 0185-3252Incluida en: BIBLAT, DOAJ, MIAR, Latindex (Catálogo 2.0)Anales Médicos es el órgano oficial de difusión de la Asociación Médica del Centro Médico ABC. Anales Médicos recibe manuscritos de investigación original e inédita, de revisión, e informes de casos clínicos, así como cartas al editor que contribuyan a enriquecer el conocimiento y desarrollo de los aspectos clínicos, epidemiológicos y básicos de la medicina, provenientes de todas las fuentes y de todos los países. También recibe manuscritos enviados por autores con especialidades o materias relacionadas con la medicina.Anales Médicos se publica con periodicidad trimestral (cuatro números por año), en formato impreso y [&hellip;]
- [Número actual](https://aidsreviews.com/es/numero-actual/): Número actual
- [Home](https://aidsreviews.com/es/): Ver publicación adelantada Para ver artículos anteriores haga click aquí. La Revista Peruana de Urología, órgano oficial de la Sociedad Peruana de Urología, está dedicada a promover el conocimiento y la práctica urológica en Perú y en Latinoamérica. Publica contenido científico de alta calidad, cumpliendo con estrictos estándares éticos y académicos, y sirve como plataforma para la difusión de investigaciones, casos clínicos e innovaciones. Publicación avanzada


[comment]: # (Generated by Hostinger Tools Plugin)